XML 49 R62.htm IDEA: XBRL DOCUMENT v3.20.1
Common Stock, and Warrants With-Down Round Protection - Schedule of Assumptions Used to Value Options (Details) - $ / shares
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dividend yield 0.00% 0.00%
Expected volatility [1] 56.32% 56.59%
Risk free interest rate 2.50% 1.31%
Expected term of options 5 years  
Exercise price $ 0.258 $ 4.5
Stock price [2] 0.258 $ 2.45
Fair value $ 0.0137  
Minimum [Member]    
Expected term of options   5 years 6 months
Fair value   $ 0.88
Maximum [Member]    
Expected term of options   6 years 6 months
Fair value   $ 0.99
[1] Due to the low trading volume of the Company's Common Stock, the expected volatility for 2019 and 2018 grant was based on a sample of 248 and 254 companies operating in the Healthcare Products industry, respectively.
[2] The Common Stock price, per share for the year ended December 31, 2019 and 2018 reflects the Company's management's estimation of the fair value per share of Common Stock. In reaching its estimation for December 31, 2018, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series D Units.